title: Quantitative Profiling of Protein Tyrosine Kinases in Human Cancer Cell Lines by Multiplexed Parallel Reaction Monitoring Assays.
abstract: Protein tyrosine kinases (PTKs) play key roles in cellular signal transduction, cell cycle regulation, cell division, and cell differentiation. Dysregulation of PTK-activated pathways, often by receptor overexpression, gene amplification, or genetic mutation, is a causal factor underlying numerous cancers. In this study, we have developed a parallel reaction monitoring-based assay for quantitative profiling of 83 PTKs. The assay detects 308 proteotypic peptides from 54 receptor tyrosine kinases and 29 nonreceptor tyrosine kinases in a single run. Quantitative comparisons were based on the labeled reference peptide method. We implemented the assay in four cell models: 1) a comparison of proliferating versus epidermal growth factor-stimulated A431 cells, 2) a comparison of SW480Null (mutant APC) and SW480APC (APC restored) colon tumor cell lines, and 3) a comparison of 10 colorectal cancer cell lines with different genomic abnormalities, and 4) lung cancer cell lines with either susceptibility (11-18) or acquired resistance (11-18R) to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib. We observed distinct PTK expression changes that were induced by stimuli, genomic features or drug resistance, which were consistent with previous reports. However, most of the measured expression differences were novel observations. For example, acquired resistance to erlotinib in the 11-18 cell model was associated not only with previously reported up-regulation of MET, but also with up-regulation of FLK2 and down-regulation of LYN and PTK7. Immunoblot analyses and shotgun proteomics data were highly consistent with parallel reaction monitoring data. Multiplexed parallel reaction monitoring assays provide a targeted, systems-level profiling approach to evaluate cancer-related proteotypes and adaptations. Data are available through Proteome eXchange Accession PXD002706.
authors.affiliation: From the ‡Jim Ayers Institute for Precancer Detection and Diagnosis and Departments of §Biochemistry and.
authors.forename: Hye-Jung
authors.initials: HJ
authors.lastname: Kim
authors.affiliation: From the ‡Jim Ayers Institute for Precancer Detection and Diagnosis and Departments of §Biochemistry and.
authors.forename: De
authors.initials: D
authors.lastname: Lin
authors.affiliation: From the ‡Jim Ayers Institute for Precancer Detection and Diagnosis and Departments of §Biochemistry and.
authors.forename: Hyoung-Joo
authors.initials: HJ
authors.lastname: Lee
authors.affiliation: ¶Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
authors.forename: Ming
authors.initials: M
authors.lastname: Li
authors.affiliation: From the ‡Jim Ayers Institute for Precancer Detection and Diagnosis and Departments of §Biochemistry and daniel.liebler@vanderbilt.edu.
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Liebler
mesh_terms: D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000235:genetics; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology; D011505:Protein-Tyrosine Kinases / Q000096:biosynthesis* / Q000235:genetics; D020543:Proteome / Q000096:biosynthesis*
chemical_list: D009363:Neoplasm Proteins; D020543:Proteome; D011505:Protein-Tyrosine Kinases